Table 2.

Characteristics of the PDT treatment cohort.

Characteristics	PDT Cohort
Total	12
Median age	49 (30–79)
Menopausal status	3 post-menopausal; 9 pre-menopausal
Estrogen (ER), Progesterone (PR) and Her 2 Receptor status: Group 1: ER + ve, PR + ve, Her 2 − ve	10
Group 2: ER − ve, PR − ve, Her 2 − ve	1
Group 3: ER + ve, PR + ve, Her 2 + ve	1
Tumor size	T2 = 4; T3 or greater = 8
Grade	G2 = 5, G3 = 7
Nodal status at mastectomy	All patients had positive nodes
Distant metastases at presentation	None
Primary treatment (after PDT)	Mastectomy
Adjuvant radiotherapy after PDT and mastectomy	12
Adjuvant chemotherapy after PDT and mastectomy	12
Adjuvant endocrine therapy after PDT and mastectomy	9